Lv41
510 积分 2023-02-02 加入
CycloSal-BVDUMP Pronucleotides: How to Convert an Antiviral-Inactive Nucleoside Analogue into a Bioactive Compound against EBV
8小时前
已完结
Design, Synthesis, and Structure–Activity Relationship of New 2-Aryl-3,4-dihydro-β-carbolin-2-ium Salts as Antifungal Agents
26天前
已完结
siRNA nanodelivery systems in the treatment of skin Diseases: Research progress and clinical translation prospects
1个月前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
1个月前
已完结
Prasinezumab: what have we learned from PASADENA and PADOVA?
2个月前
已完结
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study
2个月前
已完结
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
2个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
4个月前
已完结
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
4个月前
已完结
皖公网安备34019202002308
